Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine M Bever

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2017
An Expanding Role for Immunotherapy in Colorectal CancerKatherine M Bever, Dung T Le
The Journal of Clinical Investigation|October 2, 2018
DNA repair defects and implications for immunotherapyKatherine M Bever, Dung T Le
Molecular Cell|March 23, 2005
Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzymeJosé L Avalos, Katherine M Bever, Cynthia Wolberger
American Journal of Hematology|July 12, 2019
Prevalence and prognostic value of D-dimer elevation in patients with AL amyloidosisAnita Pudusseri, Vaishali Sanchorawala, J Mark Sloan, et al.
Journal of Visualized Experiments : Jove|January 19, 2013
Immunohistochemical staining of B7-H1 (PD-L1) on paraffin-embedded slides of pancreatic adenocarcinoma tissueElaine Bigelow, Katherine M Bever, Haiying Xu, et al.
Haematologica|October 11, 2015
Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosisKatherine M Bever, Luke I Masha, Fangui Sun, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 25, 2014
The prognostic value of stroma in pancreatic cancer in patients receiving adjuvant therapyKatherine M Bever, Elizabeth A Sugar, Elaine Bigelow, et al.
Cancer Research Communications|August 30, 2023
Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic CancerH Catherine Wilbur, Jennifer N Durham, Su Jin Lim, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 5, 2026
Post-surgical ctDNA as a prognostic biomarker for relapse of resected pancreatic ductal adenocarcinomaMatthew Z Guo, Apoorvaa S Sachidanand, Thanh Nguyen, et al.
Clinical Epigenetics|February 3, 2021
A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpointKatherine M Bever, Dwayne L Thomas, Jiajia Zhang, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2017
An Expanding Role for Immunotherapy in Colorectal CancerKatherine M Bever, Dung T Le
The Journal of Clinical Investigation|October 2, 2018
DNA repair defects and implications for immunotherapyKatherine M Bever, Dung T Le
Molecular Cell|March 23, 2005
Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzymeJosé L Avalos, Katherine M Bever, Cynthia Wolberger
American Journal of Hematology|July 12, 2019
Prevalence and prognostic value of D-dimer elevation in patients with AL amyloidosisAnita Pudusseri, Vaishali Sanchorawala, J Mark Sloan, et al.
Journal of Visualized Experiments : Jove|January 19, 2013
Immunohistochemical staining of B7-H1 (PD-L1) on paraffin-embedded slides of pancreatic adenocarcinoma tissueElaine Bigelow, Katherine M Bever, Haiying Xu, et al.
Haematologica|October 11, 2015
Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosisKatherine M Bever, Luke I Masha, Fangui Sun, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 25, 2014
The prognostic value of stroma in pancreatic cancer in patients receiving adjuvant therapyKatherine M Bever, Elizabeth A Sugar, Elaine Bigelow, et al.
Cancer Research Communications|August 30, 2023
Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic CancerH Catherine Wilbur, Jennifer N Durham, Su Jin Lim, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 5, 2026
Post-surgical ctDNA as a prognostic biomarker for relapse of resected pancreatic ductal adenocarcinomaMatthew Z Guo, Apoorvaa S Sachidanand, Thanh Nguyen, et al.
Clinical Epigenetics|February 3, 2021
A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpointKatherine M Bever, Dwayne L Thomas, Jiajia Zhang, et al.
Pageof 3